Novo Nordisk A/S

Common Name

Novo Nordisk

Country

Denmark

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

78,387

Ticker

NOVO B

Exchange

NASDAQ COPENHAGEN A/S

Website

www.novonordisk.com

Description

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, ... Show more

Financial Statements of Novo Nordisk

Below are the financial statements of Novo Nordisk, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of DKK	2024	2023	2022
Net sales	290.4^a	232.26^a	176.95^a
Cost of goods sold	-44.52^a	-35.77^a	-28.45^a
Gross profit	245.88^a	196.5^a	148.51^a
Sales and distribution costs	-62.1^a	-56.74^a	-46.22^a
Research and development costs	-48.06^a	-32.44^a	-24.05^a
Administrative costs	-5.28^a	-4.86^a	-4.47^a
Other operating income and expenses	-2.1^a	0.12^a	1.03^a
Operating profit	128.34^a	102.57^a	74.81^a
Financial income	6.2^a	2.95^a	0.24^a
Financial expenses	-7.35^a	-0.85^a	-5.99^a
Profit before income taxes	127.19^a	104.67^a	69.06^a
Income taxes	-26.2^a	-20.99^a	-13.54^a
Net profit	100.99^a	83.68^a	55.53^a

Verified Sources Behind Novo Nordisk’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novo Nordisk’s data sources below and access millions more through our Disclosure Search.

a. Novo Nordisk's Annual Report 2024

Trace every data point back to Novo Nordisk’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Novo Nordisk A/S

Financial Statements of Novo Nordisk

Verified Sources Behind Novo Nordisk’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

GN Store Nord A/S

Ascendis Pharma A/S

H Lundbeck A/S

Ambu A/S

Demant A/S

Coloplast A/S